CircRNA circ_0023984 promotes the progression of esophageal squamous cell carcinoma via regulating miR-134-5p/cystatin-s axis

Yang Ge, Yu Zhang, Hongni Lin, Jinnbo Liu, Shengjie Huang, Wei Zhong, Chao Peng, Lin DuBioengineered 2022 · DOI

TL;DR

This study reveals that a circular RNA, circ_0023984, is significantly upregulated in esophageal squamous cell carcinoma (ESCC) and promotes tumor progression. It achieves this by acting as a "sponge" for miR-134-5p, thereby releasing the inhibition of cystatin-S (CST4) expression, a protein that also contributes to ESCC malignancy. This circRNA-miRNA-protein axis presents a potential therapeutic target for ESCC.

What Problem Does This Paper Address?

Esophageal cancer (EC), particularly esophageal squamous cell carcinoma (ESCC), is a highly aggressive malignancy with a poor prognosis. While research has identified circular RNAs (circRNAs) as potential players in cancer, the specific role of circ_0023984 in ESCC progression remained unclear. This paper aims to elucidate the functional significance of circ_0023984 in ESCC, specifically investigating its impact on cell growth, invasion, and migration, and to uncover the molecular mechanisms by which it exerts its oncogenic effects.

Methods

The researchers employed a multi-pronged approach to investigate circ_0023984's role:

  • Expression Analysis: Quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure circ_0023984 levels in ESCC tissues and cell lines, as well as in normal counterparts.
  • Subcellular Localization: Subcellular fractionation assays were performed to determine whether circ_0023984 is primarily located in the nucleus or cytoplasm, which is crucial for understanding its interaction with other molecules.
  • Loss-of-Function Studies: Lentivirus-mediated shRNA knockdown was used to stably reduce circ_0023984 expression in ESCC cell lines.
  • Functional Assays: A suite of standard cell-based assays were conducted to assess the impact of circ_0023984 knockdown on:
  • Cell Proliferation: Cell Counting Kit-8 (CCK-8) and 5-Ethynyl-2'-deoxyuridine (EDU) incorporation assays.
  • Colony Formation: Colony formation assays.
  • Migration and Invasion: Transwell migration and invasion assays.
  • Molecular Interaction Studies:
    • RNA Pull-down Assay: To confirm direct binding between circ_0023984 and miR-134-5p.
  • Luciferase Reporter Assay: To validate the interaction and functional consequence of miR-134-5p binding to circ_0023984 and CST4.
  • RNA Immunoprecipitation (RIP) Assay: To assess the co-enrichment of circ_0023984 and miR-134-5p with AGO2 protein, indicating their presence in the RNA-induced silencing complex (RISC).
  • In Vivo Tumorigenesis Model: Subcutaneous tumor models in nude mice were established to evaluate the role of circ_0023984 and CST4 in tumor growth.
  • Western Blotting (WB): Used to assess protein expression levels, particularly for CST4.
  • Immunohistochemistry (IHC): Performed on tumor sections to evaluate the expression of proliferation markers (Ki-67) and CST4.

Datasets

  • GEO Dataset GSE131969: This dataset was used for initial analysis of circ_0023984 expression in ESCC tissues and normal samples.
  • TCGA Dataset: Utilized via the Starbase online tool to assess CST4 mRNA expression in ESCC patients.
  • Clinical Samples: Tissues from 70 ESCC patients and paired paraneoplastic tissues were collected and analyzed.

Key Insights and Ideas

  • Circ_0023984 as an Oncogenic Driver: The study strongly suggests that circ_0023984 is not just upregulated but actively drives ESCC progression. Its knockdown significantly impairs key malignant phenotypes.
  • The "Sponging" Mechanism: The research confirms that circRNAs can act as miRNA sponges. Circ_0023984 effectively "sequesters" miR-134-5p, preventing it from performing its normal regulatory functions.
  • A Novel Regulatory Axis: The identification of the circ_0023984/miR-134-5p/CST4 axis is a significant contribution, linking a circRNA to a specific miRNA and a downstream protein target that is also implicated in cancer.
  • CST4's Oncogenic Role: The study highlights that CST4 itself plays a role in promoting ESCC, and its upregulation is a consequence of circ_0023984's action.
  • Therapeutic Potential: The findings point towards circ_0023984 and potentially the miR-134-5p/CST4 axis as promising targets for future ESCC therapies.

Key Results

  • Upregulation in ESCC: Circ_0023984 was found to be significantly upregulated in ESCC tissues and cell lines compared to normal controls.
  • Poor Prognosis Correlation: High expression of circ_0023984 in ESCC patients was associated with significantly poorer overall survival.
  • Suppression of Malignancy: Knockdown of circ_0023984 in ESCC cells led to reduced proliferation, colony formation, migration, and invasion.
  • Interaction with miR-134-5p: Circ_0023984 directly interacts with miR-134-5p, and its knockdown leads to increased miR-134-5p levels.
  • miR-134-5p Targets CST4: miR-134-5p was shown to target the 3'UTR of CST4 mRNA, negatively regulating its expression.
  • CST4 Overexpression Rescues Effects: Overexpression of CST4 could partially rescue the suppressive effects of circ_0023984 knockdown on cell proliferation, migration, and invasion.
  • In Vivo Tumor Inhibition: Knockdown of circ_0023984 significantly inhibited tumor growth in nude mice, and CST4 overexpression partially restored tumor growth in these models.

Limitations and Future Work

  • Mechanism of circ_0023984 Upregulation: The paper acknowledges that the precise mechanisms driving the upregulation of circ_0023984 in ESCC require further investigation.
  • Broader miRNA Interactions: While the study focused on miR-134-5p, circRNAs can interact with multiple miRNAs. Future work could explore other potential miRNA targets of circ_0023984.
  • Clinical Translation: While promising, the findings are preclinical. Further research is needed to translate these discoveries into effective clinical therapies for ESCC patients.
  • Detailed Molecular Pathways: While the miR-134-5p/CST4 axis is identified, the downstream signaling pathways influenced by CST4 in ESCC could be further elucidated.

Summary updated

Abstract

Recent studies have shown that circRNAs can act as oncogenic factors or tumor suppressors by sponging microRNAs (miRNAs). The upregulation of circ_0023984 was reported in esophageal squamous cell carcinoma (ESCC). However, its functional role in ESCC remain unclear. In the present study, circ_0023984 expression in ESCC cells and tissues were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting (WB). Subcellular fraction experiment was performed to determine relative nuclear-cytoplasmic localization. The loss-of-function effects of circ_0023984 in ESCC cell lines were investigated by shRNA-mediated knockdown. Functional assays including cell Counting Kit-8 (CCK-8), 5-Ethynyl-2'-deoxyuridine (EDU) incorporation, colony formation and Transwell migration assays were conducted to assess the malignant phenotype. The interaction between the two molecules was analyzed by RNA pull-down, luciferase reporter assay and RNA immunoprecipitation (RIP). The subcutaneous tumor model in nude mice was used to assess the role of circ-0023984 in tumorigenesis. We found that ESCC patients with high circ_0023984 expression was associated with a poor prognosis. The knockdown of circ_0023984 suppressed cell growth, invasion, and migration in ESCC cells. Circ_0023984 interacted with miR-134-5p and inhibited its activity, which promoted the expression of CST4 (Cystatin-S). Circ_0023984 also regulated tumorigenesis in a CST4-dependent manner. Together, our study indicates that the oncogenic role of Circ_0023984 is mediated by miR-134-5p/CST4 Axis in ESCC, which could serve as potential targets for future therapeutic strategies.
BibTeX
@inproceedings{ge2022circrna,
  author = {Yang Ge and Yu Zhang and Hongni Lin and Jinnbo Liu and Shengjie Huang and Wei Zhong and Chao Peng and Lin Du},
  title = {{CircRNA circ\_0023984 promotes the progression of esophageal squamous cell carcinoma via regulating miR-134-5p/cystatin-s axis}},
  booktitle = {Bioengineered},
  year = {2022},
  doi = {10.1080/21655979.2022.2063562},
}
Figure